JP2010513901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513901A5 JP2010513901A5 JP2009542216A JP2009542216A JP2010513901A5 JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5 JP 2009542216 A JP2009542216 A JP 2009542216A JP 2009542216 A JP2009542216 A JP 2009542216A JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- fragment
- hox
- homeodomain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 37
- 238000000034 method Methods 0.000 claims 32
- 239000012634 fragment Substances 0.000 claims 26
- 101100285412 Gallus gallus EN2 gene Proteins 0.000 claims 16
- 108010048671 Homeodomain Proteins Proteins 0.000 claims 10
- 102000009331 Homeodomain Proteins Human genes 0.000 claims 10
- 102000040945 Transcription factor Human genes 0.000 claims 10
- 108091023040 Transcription factor Proteins 0.000 claims 10
- 210000001124 body fluid Anatomy 0.000 claims 8
- 239000010839 body fluid Substances 0.000 claims 8
- 238000001514 detection method Methods 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 8
- 206010060862 Prostate cancer Diseases 0.000 claims 7
- 238000011002 quantification Methods 0.000 claims 7
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 102100029240 Homeobox protein Hox-B5 Human genes 0.000 claims 4
- 102100025056 Homeobox protein Hox-B6 Human genes 0.000 claims 4
- 102100020759 Homeobox protein Hox-C4 Human genes 0.000 claims 4
- 101000840553 Homo sapiens Homeobox protein Hox-B5 Proteins 0.000 claims 4
- 101001077542 Homo sapiens Homeobox protein Hox-B6 Proteins 0.000 claims 4
- 101001002994 Homo sapiens Homeobox protein Hox-C4 Proteins 0.000 claims 4
- 238000002965 ELISA Methods 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 239000003446 ligand Substances 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 102100039541 Homeobox protein Hox-A3 Human genes 0.000 claims 2
- 102100034864 Homeobox protein Hox-D9 Human genes 0.000 claims 2
- 101000962622 Homo sapiens Homeobox protein Hox-A3 Proteins 0.000 claims 2
- 101001019766 Homo sapiens Homeobox protein Hox-D9 Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 239000000090 biomarker Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 2
- 229910052737 gold Inorganic materials 0.000 claims 2
- 239000010931 gold Substances 0.000 claims 2
- 238000004811 liquid chromatography Methods 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 102100031680 Beta-catenin-interacting protein 1 Human genes 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 101000993469 Homo sapiens Beta-catenin-interacting protein 1 Proteins 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 claims 1
- 238000000692 Student's t-test Methods 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000009509 drug development Methods 0.000 claims 1
- 238000007877 drug screening Methods 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- -1 for example Proteins 0.000 claims 1
- 238000001114 immunoprecipitation Methods 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 239000006249 magnetic particle Substances 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 claims 1
- 230000002250 progressing effect Effects 0.000 claims 1
- 238000003127 radioimmunoassay Methods 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 claims 1
- 238000012353 t test Methods 0.000 claims 1
- 238000004809 thin layer chromatography Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0625321.5A GB0625321D0 (en) | 2006-12-19 | 2006-12-19 | Cancer biomarker |
| GB0625321.5 | 2006-12-19 | ||
| GB0719792.4 | 2007-10-10 | ||
| GBGB0719792.4A GB0719792D0 (en) | 2006-12-19 | 2007-10-10 | Cancer biomarkers |
| PCT/GB2007/004902 WO2008075056A1 (en) | 2006-12-19 | 2007-12-19 | Cancer biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513901A JP2010513901A (ja) | 2010-04-30 |
| JP2010513901A5 true JP2010513901A5 (enExample) | 2011-01-27 |
| JP5683108B2 JP5683108B2 (ja) | 2015-03-11 |
Family
ID=39265269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542216A Expired - Fee Related JP5683108B2 (ja) | 2006-12-19 | 2007-12-19 | 癌バイオマーカー |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8460882B2 (enExample) |
| EP (1) | EP2115472B1 (enExample) |
| JP (1) | JP5683108B2 (enExample) |
| CN (1) | CN101675341B (enExample) |
| AU (1) | AU2007335999B2 (enExample) |
| BR (1) | BRPI0720371B8 (enExample) |
| CA (1) | CA2671939C (enExample) |
| CY (1) | CY1115178T1 (enExample) |
| DK (1) | DK2115472T3 (enExample) |
| ES (1) | ES2445185T3 (enExample) |
| GB (2) | GB0625321D0 (enExample) |
| IL (1) | IL199241A (enExample) |
| MX (1) | MX2009006378A (enExample) |
| NZ (1) | NZ577548A (enExample) |
| PL (1) | PL2115472T3 (enExample) |
| PT (1) | PT2115472E (enExample) |
| RU (1) | RU2460075C2 (enExample) |
| SI (1) | SI2115472T1 (enExample) |
| WO (1) | WO2008075056A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8461126B2 (en) | 2005-10-14 | 2013-06-11 | Phigenix, Inc. | Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions |
| DE102006047617B4 (de) | 2006-10-09 | 2008-11-27 | Clariant International Limited | Verfahren zur Herstellung basischer (Meth)acrylamide |
| DE102008017216B4 (de) | 2008-04-04 | 2013-08-14 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden |
| GB0823445D0 (en) * | 2008-12-23 | 2009-01-28 | Univ Surrey | Biomarker |
| DE102009031059A1 (de) | 2009-06-30 | 2011-01-05 | Clariant International Ltd. | Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen |
| WO2011007130A1 (en) * | 2009-07-13 | 2011-01-20 | The University Of Surrey | Therapeutic peptides, polypeptides ans nucleic acid sequences |
| GB0912190D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| GB0912175D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| DE102009042523B4 (de) | 2009-09-22 | 2012-02-16 | Clariant International Ltd. | Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen |
| DE102009042522A1 (de) | 2009-09-22 | 2011-04-07 | Clariant International Ltd. | Kontinuierliches Umesterungsverfahren |
| GB0921329D0 (en) * | 2009-12-04 | 2010-01-20 | Univ Surrey | Biomarker |
| DE102010056565A1 (de) | 2010-12-30 | 2012-07-05 | Clariant International Ltd. | Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere |
| US20140106363A1 (en) * | 2011-05-12 | 2014-04-17 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| CA2835728A1 (en) * | 2011-05-12 | 2012-11-15 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| CN103797120B (zh) * | 2011-09-16 | 2017-04-12 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| US20140336130A1 (en) * | 2011-12-05 | 2014-11-13 | Phigenix, Inc. | Targeting en2, pax2, and/or defb1 for treatment of prostate conditions |
| WO2014005138A1 (en) * | 2012-06-29 | 2014-01-03 | Kerschensteiner Daniel A | Colorimetric gelatinase assay |
| WO2014025961A1 (en) * | 2012-08-10 | 2014-02-13 | Analiza, Inc. | Methods and devices for analyzing species to determine diseases |
| AU2013388864B2 (en) * | 2013-05-09 | 2017-06-08 | The Procter & Gamble Company | Method and system for assessing health condition |
| WO2016102560A1 (en) * | 2014-12-23 | 2016-06-30 | The University Of Surrey | Glycosylated biomarker |
| KR101698654B1 (ko) | 2014-12-24 | 2017-01-20 | 포항공과대학교 산학협력단 | En2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| JP6745820B2 (ja) * | 2015-05-29 | 2020-08-26 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 前立腺がん予後判定の方法 |
| PL3960195T3 (pl) * | 2015-09-23 | 2025-06-09 | Centre National De La Recherche Scientifique | Engrailed do zastosowania w leczeniu stwardnienia zanikowego bocznego |
| CN106282347A (zh) * | 2016-08-17 | 2017-01-04 | 中南大学 | HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用 |
| US10508287B2 (en) | 2016-12-28 | 2019-12-17 | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences | Method for regenerating T cells and applications thereof |
| KR101777085B1 (ko) | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| KR101777259B1 (ko) * | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| KR101777254B1 (ko) * | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| CN107727729A (zh) * | 2017-11-22 | 2018-02-23 | 南宁科城汇信息科技有限公司 | 一种oa候选标志物诊断模型的建立方法 |
| CN107894507A (zh) * | 2017-11-22 | 2018-04-10 | 南宁科城汇信息科技有限公司 | 一种发现和鉴定肝癌血清差异表达蛋白和验证标志物蛋白方法 |
| KR101923199B1 (ko) | 2018-04-25 | 2018-11-28 | 주식회사 무진메디 | 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물 |
| CN111363817B (zh) * | 2018-12-26 | 2024-02-02 | 广州康立明生物科技股份有限公司 | 基于hoxd12基因的肺癌诊断剂及试剂盒 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0996725A1 (en) * | 1997-06-27 | 2000-05-03 | Human Genome Sciences, Inc. | Human nk-3 related prostate specific gene-1 |
| RU2234942C2 (ru) * | 1998-07-14 | 2004-08-27 | Корикса Корпорейшн | Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид |
| JP2002527758A (ja) * | 1998-10-19 | 2002-08-27 | ダイアデクスアス・インコーポレーテッド | 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法 |
| AU2001263771A1 (en) | 2000-05-30 | 2001-12-11 | Danmarks Miljo Undersogelser | An assay method and kit for testing biological material for exposure to stress using biomarkers |
| WO2002002806A2 (en) * | 2000-06-30 | 2002-01-10 | Epigenomics Ag | Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| US20050079492A1 (en) * | 2000-09-12 | 2005-04-14 | Burgess Jr. Robert M. | Micro-arrayed organization of transcription factor target genes |
| US20040063216A1 (en) | 2000-12-24 | 2004-04-01 | Iser Lubocki | Method for detecting biomarkers |
| NZ527180A (en) | 2000-12-24 | 2007-02-23 | Iser Lubocki | A method for detecting biomarkers |
| US20020137086A1 (en) * | 2001-03-01 | 2002-09-26 | Alexander Olek | Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| CA2469089A1 (en) * | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| US20060014301A1 (en) | 2004-07-13 | 2006-01-19 | Power3 Medical Products, Inc. | Antibody-based system for detection of differential protein expression patterns |
| ES2534139T3 (es) * | 2004-12-02 | 2015-04-17 | Epigenomics Ag | Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el pronóstico de trastornos proliferativos de células de próstata |
| WO2006089091A2 (en) * | 2005-02-18 | 2006-08-24 | Memorial Sloan-Kettering Cancer Center | Methods for detecting minimum residual disease |
-
2006
- 2006-12-19 GB GBGB0625321.5A patent/GB0625321D0/en not_active Ceased
-
2007
- 2007-10-10 GB GBGB0719792.4A patent/GB0719792D0/en not_active Ceased
- 2007-12-19 CA CA2671939A patent/CA2671939C/en active Active
- 2007-12-19 PL PL07848631T patent/PL2115472T3/pl unknown
- 2007-12-19 RU RU2009127774/15A patent/RU2460075C2/ru not_active IP Right Cessation
- 2007-12-19 JP JP2009542216A patent/JP5683108B2/ja not_active Expired - Fee Related
- 2007-12-19 DK DK07848631.3T patent/DK2115472T3/da active
- 2007-12-19 PT PT78486313T patent/PT2115472E/pt unknown
- 2007-12-19 SI SI200731399T patent/SI2115472T1/sl unknown
- 2007-12-19 MX MX2009006378A patent/MX2009006378A/es active IP Right Grant
- 2007-12-19 CN CN200780051417.9A patent/CN101675341B/zh not_active Expired - Fee Related
- 2007-12-19 ES ES07848631.3T patent/ES2445185T3/es active Active
- 2007-12-19 US US12/518,708 patent/US8460882B2/en active Active
- 2007-12-19 NZ NZ577548A patent/NZ577548A/en not_active IP Right Cessation
- 2007-12-19 EP EP07848631.3A patent/EP2115472B1/en not_active Not-in-force
- 2007-12-19 WO PCT/GB2007/004902 patent/WO2008075056A1/en not_active Ceased
- 2007-12-19 AU AU2007335999A patent/AU2007335999B2/en not_active Ceased
- 2007-12-19 BR BRPI0720371A patent/BRPI0720371B8/pt not_active IP Right Cessation
-
2009
- 2009-06-08 IL IL199241A patent/IL199241A/en active IP Right Grant
-
2014
- 2014-02-05 CY CY20141100091T patent/CY1115178T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513901A5 (enExample) | ||
| RU2009127774A (ru) | Биомаркеры рака | |
| Hudler et al. | Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics | |
| US10345309B2 (en) | Biomarkers for gastric cancer and uses thereof | |
| EP2796878A1 (en) | New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof | |
| JP4916441B2 (ja) | 結腸直腸腺腫及び/又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用;検出方法及び試験システム | |
| US20220268776A1 (en) | Biomarker panel for diagnosing pancreatic cancer and use thereof | |
| JP6774925B2 (ja) | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット | |
| EP4045912A1 (en) | Apparatuses and methods for detection of pancreatic cancer | |
| KR101520615B1 (ko) | 간암 진단용 바이오 마커 | |
| JP4516124B2 (ja) | 肝線維症の診断方法 | |
| WO2011143597A1 (en) | Methods and devices for diagnosing alzheimers disease | |
| JP2018535433A (ja) | デンスブレストを有する女性における乳癌の検出のためのバイオマーカー | |
| CN104272112B (zh) | 用于帮助诊断中风的基于生物标记的方法和生物芯片 | |
| CN105531590A (zh) | 卵巢癌生物标志物 | |
| AU2014247083B2 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| CN113234830A (zh) | 用于肺癌诊断的产品及用途 | |
| JP2012526543A5 (enExample) | ||
| US20140248637A1 (en) | Composition for diagnosis of lung cancer and diagnosis kit of lung cancer | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| WO2020021026A1 (en) | Method of diagnosing asthma subtypes | |
| EP4533094A1 (en) | Methods and systems for risk stratification and management of bladder cancer | |
| KR102346864B1 (ko) | 방광암 진단 또는 예후 분석용 바이오마커 조성물, 키트 및 이를 이용한 진단 방법 | |
| KR102235718B1 (ko) | 방광암 진단 또는 예후 분석용 바이오마커 조성물, 키트 및 이를 이용한 진단 방법 | |
| KR102136747B1 (ko) | 장형 위암의 예후 진단 마커 |